Last reviewed · How we verify

NCT03248791

Vasopressor Infusion in Cesarean Delivery

Status unknown Phase 4 Last updated 27 September 2021
What this trial tests

Phase 4 trial testing Phenylephrine in Cesarean Section Complications in 120 participants. Status unknown.

Timeline
20 August 2017
Primary endpoint
1 March 2022
10 March 2022

Quick facts

Lead sponsorCairo University
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment120
Start date20 August 2017
Primary completion1 March 2022
Estimated completion10 March 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 40, female only, with Cesarean Section Complications or Spinal Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison will be conducted between continuous variable infusions of both drugs (Phenylephrine and Norepinephrine) with starting doses of 0.75 mcg/Kg/min and 0.1 mcg/Kg/min respectively for prophylaxis against Post-spinal hypotension during cesarean delivery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Phenylephrine

Trials testing the same drug.

Other recruiting trials for Cesarean Section Complications

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03248791.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing